Porkert, S. et al. 2021. Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma. Acta Dermato-Venereologica. 101, 2 (Feb. 2021), adv00383. DOI:https://doi.org/10.2340/00015555-3746.